GLAXOSMITHKLINE LLC recorded $3.444615696 billion in obligated federal awards across 1,322 actions in the last 10 years, with an average action value of $2.61 million. Contracting activity is concentrated with the Department of the Army and in pharmaceutical preparation manufacturing.
Federal Contractor
GLAXOSMITHKLINE LLC Federal Contract Obligations (Last 10 Years)
Federal procurement overview for GLAXOSMITHKLINE LLC (CAGE 667E9, UEI FRHTPHMZMX47) covering obligations, agencies, NAICS codes, and annual trends over the last 10 years.
Figures reflect readable FPDS obligations for the last 10 years and may include multiple award actions across different agencies and NAICS codes.
CAGE Code
667E9
UEI
FRHTPHMZMX47
Total Obligated
3.44 billion
3,444,615,696.23
Award Actions
1,322
Average Action Value
2,605,609.45
About GLAXOSMITHKLINE LLC federal contract activity
GLAXOSMITHKLINE LLC recorded $3.44 billion in obligated federal awards across 1,322 actions over the last 10 years, with an average award value of $2.61 million. The profile is heavily concentrated in a small number of large obligations, led by Department of the Army activity and a strong presence in pharmaceutical and public health-related procurement channels.
Agency mix and customer concentration
The Department of the Army is the dominant customer, accounting for $2.21 billion across 87 awards, or well over half of total obligations. CDC, ASPR, and DLA represent the next tier of demand, indicating meaningful federal purchasing tied to public health readiness, biodefense, and logistics support, while VA contributes a smaller but recurring stream of awards.
Industry profile based on NAICS activity
The award base is concentrated in NAICS 325412, Pharmaceutical Preparation Manufacturing, which alone represents $2.34 billion and 1,045 awards. Secondary activity appears in medical supply wholesaling and biologics manufacturing, with additional obligations in medicinal and botanical manufacturing and biotechnology R&D, reinforcing a portfolio centered on drug, biologics, and related health-product acquisition.
Annual contract trend over the analysis window
Obligations were highly uneven over the period, with major spikes in 2021 and 2022 totaling about $1.97 billion combined, far exceeding later years. Activity declined sharply after 2022, with 2023 through 2025 remaining in the tens of millions annually, suggesting the vendor’s federal spend was front-loaded by large pandemic-era or readiness-related procurements.
How to interpret this page
This summary is based on FPDS award data for CAGE 667E9 / UEI FRHTPHMZMX47 over the last 10 years. Totals reflect obligated dollars and award counts as reported in the provided dataset; agency, NAICS, and annual views are ranked by total obligated amount.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 2100 | DEPT OF THE ARMY | 2,214,443,300.50 | 2.21 billion | 87 |
| 7523 | CENTERS FOR DISEASE CONTROL AND PREVENTION | 903,146,139.17 | 903.15 million | 133 |
| 7505 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | 194,620,413.22 | 194.62 million | 138 |
| 97AS | DEFENSE LOGISTICS AGENCY | 80,725,518.82 | 80.73 million | 375 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 21,978,772.46 | 21.98 million | 177 |
| 7527 | INDIAN HEALTH SERVICE | 13,675,399.84 | 13.68 million | 16 |
| 7570 | OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA) | 5,880,439.30 | 5.88 million | 67 |
| 1900 | STATE, DEPARTMENT OF | 5,418,515.03 | 5.42 million | 21 |
| 1549 | FEDERAL BUREAU OF INVESTIGATION | 2,185,882.91 | 2.19 million | 32 |
| 1540 | FEDERAL PRISON SYSTEM / BUREAU OF PRISONS | 1,697,332.23 | 1.70 million | 257 |
Insight
Over the last 10 years, GLAXOSMITHKLINE LLC’s obligations are highly concentrated in the DEPT OF THE ARMY, which accounts for $2.21 billion of the vendor’s $3.44 billion total obligated, or roughly 64%. The next largest agency, CDC, represents $903.15 million, while all remaining agencies are well below $200 million each, indicating a steep drop-off after the top two buyers. Award activity is more dispersed than dollars: DLA, Bureau of Prisons, and VA each show relatively high award counts but comparatively low obligated values, suggesting many smaller awards outside the primary funding streams.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 2,338,108,117.88 | 2.34 billion | 1,045 |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | 682,513,624.91 | 682.51 million | 20 |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 167,071,140.08 | 167.07 million | 81 |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | 116,625,761.09 | 116.63 million | 46 |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 107,425,385.99 | 107.43 million | 68 |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | 33,346,295.00 | 33.35 million | 22 |
| 493120 | REFRIGERATED WAREHOUSING AND STORAGE | 1,473,882.86 | 1.47 million | 31 |
| 339999 | ALL OTHER MISCELLANEOUS MANUFACTURING | 2,448.75 | 2.45 thousand | 1 |
| 339113 | SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING | -8,947.48 | -8.95 thousand | 3 |
| 446110 | PHARMACIES AND DRUG STORES | -10,608.96 | -10.61 thousand | 1 |
Insight
GLAXOSMITHKLINE LLC’s obligations over the last 10 years are highly concentrated in NAICS 325412, Pharmaceutical Preparation Manufacturing, which accounts for $2.34 billion across 1,045 awards, or roughly two-thirds of the vendor’s $3.44 billion total. The next largest NAICS, 423450, Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, represents a much smaller share at $682.51 million but is concentrated in only 20 awards, indicating higher-dollar transactions in that category. Remaining obligations are distributed across biologics, medicinal/botanical manufacturing, biotechnology R&D, and related life sciences codes, with materially lower dollar volumes and award counts; minor negative obligations appear in two small categories.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 29,898,698.95 | 29.90 million | 52 |
| 2024 | 62,713,697.07 | 62.71 million | 153 |
| 2023 | 18,566,762.98 | 18.57 million | 59 |
| 2022 | 1,006,991,125.58 | 1.01 billion | 201 |
| 2021 | 969,631,043.83 | 969.63 million | 69 |
| 2020 | 368,893,859.55 | 368.89 million | 179 |
| 2019 | 45,625,090.47 | 45.63 million | 241 |
| 2018 | 124,138,487.53 | 124.14 million | 181 |
| 2017 | 809,880,890.22 | 809.88 million | 180 |
| 2016 | 8,276,040.05 | 8.28 million | 7 |
Insight
Over the last 10 years, GLAXOSMITHKLINE LLC’s obligations totaled $3.44 billion across 1,322 awards, with activity heavily concentrated in 2021–2022. Those two years accounted for about $1.98 billion combined, or more than half of total obligations in the period, driven by $969.63 million in 2021 and $1.01 billion in 2022. Outside that peak, obligations were materially lower and more variable, ranging from $8.28 million in 2016 to $809.88 million in 2017, with recent years declining to $62.71 million in 2024 and $29.90 million in 2025.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.